STOCK TITAN

Twist Bioscience (TWST) Form 144 Reports 269-Share Sale; Prior Sales Total 1,755 Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Twist Bioscience (TWST) filed a Form 144 reporting a proposed insider sale of common stock and recent related transactions. The notice shows 269 shares that vested as restricted stock on 09/05/2025 and are planned for sale on 09/08/2025 through Fidelity Brokerage Services (NASDAQ). The filing lists an aggregate market value for the 269 shares of $6,929.41 and identifies the payment as compensation for the vesting. The filer also reported five open-market sales by the same person over the prior three months totaling 1,755 shares for gross proceeds of $51,687.54. The filer certifies no undisclosed material information.

Positive

  • Vested shares identified (269 shares acquired 09/05/2025 via restricted stock vesting), clarifying the basis for sale
  • Broker identified (Fidelity Brokerage Services LLC), providing a clear execution channel for the sale
  • Full disclosure of prior sales in the preceding three months, improving transparency

Negative

  • Insider sold 1,755 shares in the past three months for aggregate gross proceeds of $51,687.54, which may be viewed negatively by some investors
  • Proposed sale has an aggregate market value of $6,929.41 for the 269 shares, indicating additional insider liquidity

Insights

TL;DR: Routine insider sale filing: small equity vesting and disclosed market sales; not clearly material to company fundamentals.

The Form 144 documents a typical post-vesting sale process: 269 shares vested and are designated for sale via a broker, with prior open-market dispositions totaling 1,755 shares and $51,687.54 in proceeds. Transaction sizes are small relative to a public company scale and are recorded as compensation-related. The filing contains no new operational or financial data about Twist Bioscience and includes the standard representation that no material nonpublic information is held.

TL;DR: Disclosure complies with Rule 144 mechanics; the pattern of recent sales is visible but not necessarily material.

The notice properly identifies the acquisition method (restricted stock vesting) and the broker. The recent sales history is fully reported, enabling transparency about insider liquidity. There is no indication of trading plan adoption dates or other commentary in the filing. From a governance perspective, documentation appears routine and complete for a Form 144.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TWST Form 144 report?

It reports a proposed sale of 269 common shares that vested 09/05/2025 and are planned for sale on 09/08/2025 through Fidelity Brokerage Services.

How many shares did the insider sell in the past three months for TWST?

The filer sold 1,755 shares across five transactions on 06/16/2025, 06/20/2025, 07/02/2025, 08/04/2025 and 08/21/2025.

What were the gross proceeds from recent insider sales reported in the filing?

Gross proceeds totaled $51,687.54 from the five reported sales in the prior three months.

How were the 269 shares acquired according to the filing?

The 269 shares were acquired via restricted stock vesting on 09/05/2025 and payment is listed as compensation.

Which broker will handle the proposed sale of TWST shares?

Fidelity Brokerage Services LLC is named as the broker for the proposed sale.
Twist Bioscience

NASDAQ:TWST

View TWST Stock Overview

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

2.73B
60.41M
Diagnostics & Research
Biological Products, (no Diagnostic Substances)
Link
United States
SOUTH SAN FRANCISCO